Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

ResMed Inc. (RMD) had Revenue of $1.35B for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$1.35B
Net Income	$379.70M
Cost of Goods Sold	$527.93M
Gross Profit	$820.07M
Operating Expenses	$893.45M
Operating Income	$454.54M
Non-Operating Income/Expense	$3.51M
Pre-Tax Income	$458.05M
Normalized Pre-Tax Income	$458.05M
Income after Taxes	$379.70M
Income from Continuous Operations	$379.70M
Consolidated Net Income/Loss	$379.70M
Normalized Income after Taxes	$379.70M
EBIT	$454.54M
EBITDA	$528.83M
Weighted-Average Shares Outstanding (Basic)	146.72M
Weighted-Average Shares Outstanding (Diluted)	147.34M
Earnings per Share (EPS) (Basic)	$2.59
Earnings per Share (EPS) (Diluted)	$2.58
Balance Sheet Financials
Current Assets	$3.51B
Property, Plant, and Equipment	$550.79M
Long-Term Assets	$4.67B
Total Assets	$8.17B
Current Liabilities	$1.02B
Long-Term Debt	$658.39M
Long-Term Liabilities	$1.19B
Total Liabilities	$2.21B
Common Equity	$5.97B
Tangible Shareholders Equity	$2.46B
Shareholders Equity	$5.97B
Common Shares Outstanding	146.38M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.75B
Cash Flow from Investing Activities	$-200.04M
Cash Flow from Financial Activities	$-606.25M
Beginning Cash	$238.36M
End Cash	$1.21B
Increase/Decrease in Cash	$971.09M
Stock-Based Compensation	$91.66M
Common Stock Dividends Paid	$-310.88M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.10
Debt to Equity Ratio	0.11
Gross Margin	60.84%
Operating Margin	33.72%
EBIT Margin	33.72%
EBITDA Margin	--
Pre-Tax Profit Margin	33.98%
Profit Margin	28.17%
Free Cash Flow	$1.66B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.57
Receiveable Turnover	1.43
Days Sales in Receivables	62.73
Return on Equity	6.36%
Return on Tangible Equity	15.46%
Return on Assets	4.65%
Return on Investments	5.73%
Book Value Per Share	$40.77
Free Cash Flow per Share	$11.28
Operating Cash Flow per Share	$11.89

Data from Zacks Investment Research, Inc.